Prof. Jean Calleja Agius from the Department of Anatomy, Faculty of Medicine and Surgery, has been appointed the chairperson of GYNOCARE COST Action (CA18117).

GYNOCARE is a European Network for Gynaecological Rare Cancer research: From Concept to Cure.

Approximately 18.5 million women annually are affected by gynaecological cancer, with more than half being classified as rare cancers. Delayed diagnosis of patients suffering from rare gynaecological cancers leads to poor outcomes and contributes to a huge socio-economic burden.

This field is lagging behind due to distinct scientific and technological challenges that gynaecological cancer research faces. Currently, the overall efforts for addressing these challenges are fragmented across different European countries and beyond. 

GYNOCARE aims to create a unique network between key stakeholders covering these distinct domains: conducting basic research on rare gynaecological cancer, biobanking, bridging the gap with the pharmaceutical industry, and establishing legal and regulatory requirements for international trials and other research collaborative efforts. To achieve these ambitious goals, research coordination and capacity building objectives have been devised in accordance with mission and vision of the COST Action, including the provision of equal networking opportunities for early-stage researchers, and other talented young professionals.

More information on this COST Action can be found online.

Should you or your team be interested to join, please email the Chairperson directly. 

In the meantime, watch out for the upcoming launch of the brand new website of GYNOCARE.